Lori A Karol1, Donald Virostek2, Kevin Felton2, ChanHee Jo2, Lesley Butler2. 1. Departments of Orthopaedic Surgery (L.A.K. and L.B.), Prosthetics and Orthotics (D.V. and K.F.), and Research (C.H.J.), Texas Scottish Rite Hospital for Children, Dallas, Texas lori.karol@tsrh.org. 2. Departments of Orthopaedic Surgery (L.A.K. and L.B.), Prosthetics and Orthotics (D.V. and K.F.), and Research (C.H.J.), Texas Scottish Rite Hospital for Children, Dallas, Texas.
Abstract
BACKGROUND: To determine the influence of the Risser sign on the need for surgery in children wearing orthoses for the treatment of adolescent idiopathic scoliosis (AIS), data on compliance with brace wear were collected and analyzed. METHODS: One hundred and sixty-eight patients were prospectively enrolled at the time that brace wear had been prescribed and were followed until the cessation of bracing or the need for surgery. Inclusion criteria were a curve magnitude between 25° and 45°; a Risser stage of 0, 1, or 2; and, if female, <1 year post menarche at the time of brace prescription. Compliance was measured using thermal monitors. RESULTS: The prevalence of surgery, or progression to a curve magnitude of ≥50°, was 44.2% for patients at Risser stage 0 (n = 120), 6.9% for patients at Risser stage 1 (n = 29), and 0% for patients at Risser stage 2 (n = 19). Brace wear averaged 11.3, 13.4, and 14.2 hours per day for the Risser stage-0, 1, and 2 groups, respectively. While the groups had no difference in initial curve magnitude (p = 0.11), more patients at Risser stage 0 had progression to surgery than did patients at Risser stage 1 or stage 2 despite bracing (p < 0.0001). Twenty-six (41.9%) of 62 Risser stage-0 patients who wore braces ≥12.9 hours per day had progression to surgery. Ten patients at Risser stage 0 with closed triradiate cartilage wore braces ≥18 hours per day, and none underwent surgery. In comparison, 7 of 10 patients at Risser stage 0 with open triradiate cartilage and similar daily brace wear underwent surgery. Of 9 patients at Risser stage 0 with open triradiate cartilage who wore braces ≥12.9 hours daily for curves measuring <30°, 7 had a nonsurgical outcome. CONCLUSIONS: Patients at Risser stage 0 are at risk for surgery despite brace wear. In these patients, 12.9 hours of daily wear-the number of hours linked with a successful outcome in the BRAIST (Bracing in Adolescent Idiopathic Scoliosis Trial)-did not prevent surgery. Patients with open triradiate cartilage were at highest risk, especially those with curves of ≥30°. Risser stage-0 patients should be prescribed a minimum of 18 hours of brace wear. Bracing should be initiated for curves of <30° in patients at Risser stage 0, especially those with open triradiate cartilage. LEVEL OF EVIDENCE: Prognostic Level II. See Instructions for Authors for a complete description of levels of evidence.
BACKGROUND: To determine the influence of the Risser sign on the need for surgery in children wearing orthoses for the treatment of adolescent idiopathic scoliosis (AIS), data on compliance with brace wear were collected and analyzed. METHODS: One hundred and sixty-eight patients were prospectively enrolled at the time that brace wear had been prescribed and were followed until the cessation of bracing or the need for surgery. Inclusion criteria were a curve magnitude between 25° and 45°; a Risser stage of 0, 1, or 2; and, if female, <1 year post menarche at the time of brace prescription. Compliance was measured using thermal monitors. RESULTS: The prevalence of surgery, or progression to a curve magnitude of ≥50°, was 44.2% for patients at Risser stage 0 (n = 120), 6.9% for patients at Risser stage 1 (n = 29), and 0% for patients at Risser stage 2 (n = 19). Brace wear averaged 11.3, 13.4, and 14.2 hours per day for the Risser stage-0, 1, and 2 groups, respectively. While the groups had no difference in initial curve magnitude (p = 0.11), more patients at Risser stage 0 had progression to surgery than did patients at Risser stage 1 or stage 2 despite bracing (p < 0.0001). Twenty-six (41.9%) of 62 Risser stage-0 patients who wore braces ≥12.9 hours per day had progression to surgery. Ten patients at Risser stage 0 with closed triradiate cartilage wore braces ≥18 hours per day, and none underwent surgery. In comparison, 7 of 10 patients at Risser stage 0 with open triradiate cartilage and similar daily brace wear underwent surgery. Of 9 patients at Risser stage 0 with open triradiate cartilage who wore braces ≥12.9 hours daily for curves measuring <30°, 7 had a nonsurgical outcome. CONCLUSIONS:Patients at Risser stage 0 are at risk for surgery despite brace wear. In these patients, 12.9 hours of daily wear-the number of hours linked with a successful outcome in the BRAIST (Bracing in Adolescent Idiopathic Scoliosis Trial)-did not prevent surgery. Patients with open triradiate cartilage were at highest risk, especially those with curves of ≥30°. Risser stage-0 patients should be prescribed a minimum of 18 hours of brace wear. Bracing should be initiated for curves of <30° in patients at Risser stage 0, especially those with open triradiate cartilage. LEVEL OF EVIDENCE: Prognostic Level II. See Instructions for Authors for a complete description of levels of evidence.
Authors: M J Troy; P E Miller; N Price; V Talwalkar; F Zaina; S Donzelli; S Negrini; M T Hresko Journal: Eur Spine J Date: 2018-11-16 Impact factor: 3.134
Authors: Lori A Dolan; Stuart L Weinstein; Mark F Abel; Patrick P Bosch; Matthew B Dobbs; Tyler O Farber; Matthew F Halsey; M Timothy Hresko; Walter F Krengel; Charles T Mehlman; James O Sanders; Richard M Schwend; Suken A Shah; Kushagra Verma Journal: Spine Deform Date: 2019-11
Authors: Abdul Fettah Buyuk; Walter H Truong; Sara J Morgan; Andrew J Snyder; Dan J Miller; Kristine K Nolin; Kristin J Smith Journal: Spine Deform Date: 2021-10-21
Authors: Xue Li; Zhaohua Huo; Zongshan Hu; Tsz Ping Lam; Jack Chun Yiu Cheng; Vincent Chi-Ho Chung; Benjamin Hon Kei Yip Journal: PLoS One Date: 2022-07-20 Impact factor: 3.752
Authors: Manon van den Bogaart; Barend J van Royen; Tsjitske M Haanstra; Marinus de Kleuver; Sayf S A Faraj Journal: Eur Spine J Date: 2019-01-03 Impact factor: 3.134